NCT00398216View on ClinicalTrials.gov

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

903

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

ThrombosisHip Replacement

Interventions

DRUG

DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor

Trial Locations (29)

Unknown

Hartford

Sarasota

Austin

Ajax

Cambridge

Guelph

Kitchner

Toronto

Hellerup

Herlev

Hørsholm

Gyula

Kecskemét

Szeged

Riga

Krasnoyarsk

Moscow

Saint Petersburg

Saratov

Veliky Novgorod

Volgograd

Chernivtsy

Dnipro

Donetsk

Kharkiv

Kiev

Lutsk

Lviv

Odesa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY